Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's Syndrome

Neuroendocrine tumor (NET) occurring in association with other endocrine syndromes forms a distinct entity. The aim was to assess the therapy response profile of the routine peptide receptor radionuclide therapy (PRRT) in this relatively uncommon but clinically challenging subgroup of patients. A re...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Chinna, Basu, Sandip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436318/
https://www.ncbi.nlm.nih.gov/pubmed/28553179
http://dx.doi.org/10.4103/1450-1147.203068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436318/
https://www.ncbi.nlm.nih.gov/pubmed/28553179
http://dx.doi.org/10.4103/1450-1147.203068

Ejemplares similares